Article
The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1.
Journal of experimental & clinical cancer research : CR - 17 Jan 2022
Guo Jing, Li Chuzhong, Fang Qiuyue, Liu Yulou, Wang Dawei, Chen Yiyuan, Xie Weiyan, Zhang Yazhuo
Abstract excerpt
BACKGROUND: Recently, a hotspot mutation in prolactinoma was observed in splicing factor 3b subunit 1 (SF3B1R625H), but its functional effects and underlying molecular mechanisms remain largely unexplored. METHODS: Using the CRISPR/Cas9 genome editing system and rat pituitary GH3 cells, we generated heterozygous Sf3b1R625H mutant cells. Sanger and whole-genome sequencing were conducted to verify the introduction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
